mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.4 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |